1 |
Ivanova E, Asadullina D, Rakhimov R, Izmailov A, Izmailov A, Gilyazova G, Galimov S, Pavlov V, Khusnutdinova E, Gilyazova I. Exosomal miRNA-146a is downregulated in clear cell renal cell carcinoma patients with severe immune-related adverse events. Non-coding RNA Research 2022;7:159-63. [DOI: 10.1016/j.ncrna.2022.06.004] [Reference Citation Analysis]
|
2 |
Olivieri F, Prattichizzo F, Giuliani A, Matacchione G, Rippo MR, Sabbatinelli J, Bonafè M. miR-21 and miR-146a: The microRNAs of inflammaging and age-related diseases. Ageing Res Rev 2021;70:101374. [PMID: 34082077 DOI: 10.1016/j.arr.2021.101374] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 26.0] [Reference Citation Analysis]
|
3 |
Keewan E, Beg S, Naser SA. Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling. Front Immunol 2021;12:641295. [PMID: 34025650 DOI: 10.3389/fimmu.2021.641295] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Zhang J, Tan H, Cao Q, Su G, Yang P. Meta-Analysis of miRNA Variants Associated with Susceptibility to Autoimmune Disease. Dis Markers 2021;2021:9978460. [PMID: 34659590 DOI: 10.1155/2021/9978460] [Reference Citation Analysis]
|
5 |
Keewan E, Matlawska-Wasowska K. The Emerging Role of Suppressors of Cytokine Signaling (SOCS) in the Development and Progression of Leukemia. Cancers (Basel) 2021;13:4000. [PMID: 34439155 DOI: 10.3390/cancers13164000] [Reference Citation Analysis]
|
6 |
Mir R, Tayeb FJ, Barnawi J, Jalal MM, Saeedi NH, Hamadi A, Altayar MA, Alshammari SE, Mtiraoui N, Ali ME, Duhier FMA, Ullah MF. Biochemical Characterization and Molecular Determination of Estrogen Receptor-α (ESR1 PvuII-rs2234693 T>C) and MiRNA-146a (rs2910164 C>G) Polymorphic Gene Variations and Their Association with the Risk of Polycystic Ovary Syndrome. IJERPH 2022;19:3114. [DOI: 10.3390/ijerph19053114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|